Arthrosi Therapeutics has raised $153 million to bankroll its bid to clout gout. The series E financing gives the biotech the financial firepower to deliver data from two phase 3 trials next year. San ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback